Q statistics to assess homogeneity / consistency

                   Q df p-value
Total           6.62  9  0.6770
Within designs  5.41  6  0.4929
Between designs 1.21  3  0.7506

Design-specific decomposition of within-designs Q statistic

                   Design    Q df p-value
     Placebo:Efruxifermin 1.69  1  0.1934
       Placebo:Resmetirom 1.57  1  0.2107
     Placebo:Cenicriviroc 1.22  1  0.2692
     Placebo:Pioglitazone 0.74  1  0.3908
 Placebo:Obeticholic acid 0.18  1  0.6675
       Placebo:Aldafermin 0.01  1  0.9395

Between-designs Q statistic after detaching of single designs
(influential designs have p-value markedly different from 0.7506)

                Detached design    Q df p-value
           Placebo:Cenicriviroc 0.60  2  0.7408
             Placebo:Tropifexor 0.60  2  0.7408
           Placebo:Pioglitazone 1.05  2  0.5925
 Placebo:Pioglitazone:Vitamin E 0.61  1  0.4348

Q statistic to assess consistency under the assumption of
a full design-by-treatment interaction random effects model

                   Q df p-value tau.within tau2.within
Between designs 1.21  3  0.7506          0           0
